PharmaSource Podcast

How EU Sustainability Regulations Are Reshaping CDMO Manufacturing

“Rather than saying that there’s a gap from the industry, I think there’s a listening gap from our governments.” Neha Dave is an independent EU Government Affairs Adviso

"Stop Talking About Resilience in the Future Tense": What Pharma Actually Wants From CDMOs

Moderated by Raman Sehgal, Host of Molecule to Market, this opening panel at CDMO Live Europe 2026 brought together Melanie Wamsler, External Network Strategy Lead, Taked

Abzena on AOCs: Building US Capacity to Compete With China

“There isn’t enough capacity for antibody-oligo conjugates out there today, full stop,” says Geoff Glass, CEO of Abzena. “And it’s really because of the volume requiremen

“Mexico Is the New China”: Reshoring Institute Executive Director Rosemary Coates on the Future of Pharmaceutical Reshoring

“If you look at the employment numbers in the manufacturing sector, it’s been absolutely flat for two years. The political noise has not driven that big wave of reshoring

How Cognition Therapeutics Cut Cost of Goods by 85% Through Smarter CMC Strategy

“No one is going to care about your project as much as you do.”  Steven Weissman is Vice President and Head of CMC at Cognition Therapeutics, a small pharma company outs

How to Connect a CDMO Network Without Starting From Scratch

“Digital collaboration is a competitive advantage for everyone — for CDMOs and CMOs, it’s not a question of if you’re going to do it, it’s when. So how do you get ready f

CDMO Relationship Management Across the Americas: Why Culture Changes Everything

“When we go to an external partner, we need to show up as one single aligned organization. If we’re not aligned internally, the CMO ends up becoming the referee.” In ph

How To Complete a Dual-Site Biologics Tech Transfer in 90 Days

At CDMO Live Europe 2026, Jeff Mason, VP and Head of US Sales at Samsung Biologics, demonstrated a risk-based, parallel approach to dual-site technology transfer that del

When Outsourcing Goes Wrong

When relationships with contract manufacturers break down, the cause is rarely just the contract manufacturer. A panel of three sponsor-side executives examined the warni

Why the Least Expensive CDMO Could Cost the Most

“The least expensive CDMO on the first day of bidding may not be the optimum value CDMO three years later.” Choosing a contract development and manufacturing organizatio

“One Size Doesn’t Fit All”: CRAMSN COO on Serving Biotechs and Big Pharma Under One Roof

At CDMO Live Europe, Dr. Vijay Vittal Mathad, Chief Operating Officer of CRAMSN Research Park, outlined how a genuine end-to-end CDMO model reduces friction across the dr

How To Deliver a High-Concentration Bispecific Antibody Tox Batch in 4 Months

Leon Tian, Director of US Project Management, ProBio, walked through the cell line development, high-concentration formulation, and purification workflow, delivering a bi

Novartis’ Win-Win Approach to Greener Drug Development

“Environmental Sustainability can be a substantial differentiator for CDMOs” Jürgen Wieland, Development Environmental Sustainability Lead at Novartis, is engaged to int

Network Resilience: Why Dual Sourcing Alone Won’t Save You

At CDMO Live Europe 2026, a panel of pharma and CDMO executives examined how supply chains must be redesigned for a world of sustained geopolitical pressure, regulatory f

Building a CMC Strategy That Satisfies Regulators and Attracts Investors

“Projects quite often realize too late that their R&D process cannot just be copy-pasted from the lab into the manufacturing facility.” Dr. Jenny Prange is Head of Proje

How Polpharma Transferred 21 Products Across Five CDMOs

Andrzej Hoczyk, External Supply Operations (ESO) Head at Polpharma, presented the case for treating large-scale tech transfer as a managed program rather than a series of

How Bayer Builds Lasting CDMO Partnerships Through Trust and Constructive Tension

"The quality of any relationship becomes most visible during times of challenge and pressure," says Frederik Krekeler. Frederik Krekeler is Head of Procurement for Bayer

The Rezon Bio Story: Interview with Dr. Adriana Kiedzierska-Mencfeld

At CDMO Live Europe 2026, Dr. Adriana Kiedzierska-Mencfeld, Chief Executive Officer of Rezon Bio, drew on 11 years of leading operations at Polpharma Biologics to explain

CMC Strategies Transforming Biologics Drug Development

“CMC was not usually a core part of the planning — it was more of an afterthought. Now that funding has tightened, that is changing.” Siddhartha Jain, President of Shool

Strategic Procurement: How To Build Win-Win CDMO Alliances Beyond Price

At CDMO Live Europe 2025, a panel of procurement and commercial leaders argued that the most consequential CDMO negotiations happen after the contract is signed, covering